Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 159 articles:
HTML format
Text format



Single Articles


    September 2017
  1. KUDOU M, Shiozaki A, Fujiwara H, Konishi H, et al
    Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer.
    Anticancer Res. 2017;37:5301-5307.
    PubMed     Text format     Abstract available


  2. SOHDA M, Kumakura Y, Saito H, Kuriyama K, et al
    Clinical Significance of Salvage Esophagectomy for Patients with Esophageal Cancer and Factors of Influencing Long-term Survival.
    Anticancer Res. 2017;37:5045-5051.
    PubMed     Text format     Abstract available


  3. KUMABE A, Zenda S, Motegi A, Onozawa M, et al
    Long-term Clinical Results of Concurrent Chemoradiotherapy for Patients with Cervical Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5039-5044.
    PubMed     Text format     Abstract available


    August 2017
  4. WANG Y, Li D, Liu R, Jia C, et al
    Application of Ultrasound-guided Core Needle Biopsy in the Diagnosis of T3 or T4 Stage Laryngeal and Hypopharyngeal Cancer.
    Anticancer Res. 2017;37:4563-4567.
    PubMed     Text format     Abstract available


  5. LV Y, Jia C, Jiang A, Zhang H, et al
    Analysis of Association Between MGMT and p53 Gene Single Nucleotide Polymorphisms and Laryngeal Cancer.
    Anticancer Res. 2017;37:4399-4403.
    PubMed     Text format     Abstract available


  6. MOTOYAMA S, Sato Y, Maruyama K, Usami S, et al
    Metabolic Rather than Pathological Response to Preoperative Chemoradiotherapy Is a Stronger Predictor of Survival in cStage IIB-IV Esophageal Cancer.
    Anticancer Res. 2017;37:4189-4194.
    PubMed     Text format     Abstract available


  7. HONJO H, Toh Y, Sohda M, Suzuki S, et al
    Clinical Significance and Phenotype of MTA1 Expression in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:4147-4155.
    PubMed     Text format     Abstract available


  8. PARK Y, Son JY, Lee BM, Kim HS, et al
    Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose.
    Anticancer Res. 2017;37:4139-4146.
    PubMed     Text format     Abstract available


  9. KLATKA J, Grywalska E, Hymos A, Guz M, et al
    Cyclooxygenase-2 Inhibition Enhances Proliferation of NKT Cells Derived from Patients with Laryngeal Cancer.
    Anticancer Res. 2017;37:4059-4066.
    PubMed     Text format     Abstract available


  10. WANG Y, Xu G, Wang J, Li XH, et al
    Relationship of Th17/Treg Cells and Radiation Pneumonia in Locally Advanced Esophageal Carcinoma.
    Anticancer Res. 2017;37:4643-4647.
    PubMed     Text format     Abstract available


  11. ZHANG W, Yin G, Dai J, Sun YU, et al
    Chemoprevention by Quercetin of Oral Squamous Cell Carcinoma by Suppression of the NF-kappaB Signaling Pathway in DMBA-treated Hamsters.
    Anticancer Res. 2017;37:4041-4049.
    PubMed     Text format     Abstract available


  12. REITER M, Harreus U
    Total Glossectomy Without Laryngectomy for Advanced Squamous Cell Cancer of the Tongue: Functional and Oncological Results.
    Anticancer Res. 2017;37:4233-4237.
    PubMed     Text format     Abstract available


    July 2017
  13. KITAGAWA H, Namikawa T, Hanazaki K
    Neck Dissection and Thoracoscopic Esophagectomy in Esophageal Cancer with Aberrant Subclavian Artery.
    Anticancer Res. 2017;37:3787-3790.
    PubMed     Text format     Abstract available


  14. HONMA Y, Hokamura N, Nagashima K, Sudo K, et al
    Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.
    Anticancer Res. 2017;37:3741-3749.
    PubMed     Text format     Abstract available


  15. USLU U, Schuler G, Breuninger H
    Factors Influencing Disease Progression in Patients with Head and Neck Melanoma.
    Anticancer Res. 2017;37:3811-3816.
    PubMed     Text format     Abstract available


  16. FENG X, Matsuo K, Zhang T, Hu Y, et al
    MicroRNA Profiling and Target Genes Related to Metastasis of Salivary Adenoid Cystic Carcinoma.
    Anticancer Res. 2017;37:3473-3481.
    PubMed     Text format     Abstract available


    June 2017
  17. KAWAI T, Kochi M, Fujii M, Song K, et al
    Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:3301-3306.
    PubMed     Text format     Abstract available


  18. KALFERT D, Ludvikova M, Topolcan O, Celakovsky P, et al
    Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:3281-3286.
    PubMed     Text format     Abstract available


  19. UCHIYAMA Y, Kreiborg S, Murakami S, Tsujimoto T, et al
    Changes in the Submandibular Gland in Patients with Head and Neck Cancer After Radiation Therapy: A Preliminary Study.
    Anticancer Res. 2017;37:3239-3242.
    PubMed     Text format     Abstract available


  20. TARVAINEN L, Suojanen J, Kyyronen P, Lindqvist C, et al
    Occupational Risk for Oral Cancer in Nordic Countries.
    Anticancer Res. 2017;37:3221-3228.
    PubMed     Text format     Abstract available


  21. SUZUKI G, Yamazaki H, Aibe N, Masui K, et al
    Palliative Radiotherapy in the Local Management of Stage IVB Esophageal Cancer: Factors Affecting Swallowing and Survival.
    Anticancer Res. 2017;37:3085-3092.
    PubMed     Text format     Abstract available


  22. MIYATA H, Sugimura K, Motoori M, Fujiwara Y, et al
    Clinical Assessment of Sarcopenia and Changes in Body Composition During Neoadjuvant Chemotherapy for Esophageal Cancer.
    Anticancer Res. 2017;37:3053-3059.
    PubMed     Text format     Abstract available


  23. ARATANI K, Komatsu S, Ichikawa D, Ohashi T, et al
    Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2017;37:3129-3135.
    PubMed     Text format     Abstract available


  24. JANG S, Patel PN, Kimple RJ, McCulloch TM, et al
    Clinical Outcomes and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.
    Anticancer Res. 2017;37:3045-3052.
    PubMed     Text format     Abstract available


  25. KRAMER B, Hock C, Schultz JD, Lammert A, et al
    Impact of Small Molecules on beta-Catenin and E-Cadherin Expression in HPV16-positive and -negative Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:2845-2852.
    PubMed     Text format     Abstract available


    May 2017
  26. RADES D, Maderer A, Panzner A, Hunold P, et al
    Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal Cancer.
    Anticancer Res. 2017;37:2703-2708.
    PubMed     Text format     Abstract available


  27. ZIVICOVA V, Broz P, Fik Z, Mifkova A, et al
    Genome-wide Expression Profiling (with Focus on the Galectin Network) in Tumor, Transition Zone and Normal Tissue of Head and Neck Cancer: Marked Differences Between Individual Patients and the Site of Specimen Origin.
    Anticancer Res. 2017;37:2275-2288.
    PubMed     Text format     Abstract available


  28. HAGEMANN J, Jacobi C, Hahn M, Schmid V, et al
    Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer.
    Anticancer Res. 2017;37:2201-2210.
    PubMed     Text format     Abstract available


  29. CIESIELSKA U, Zatonski T, Nowinska K, Ratajczak-Wielgomas K, et al
    Expression of Cell Cycle-related Proteins p16, p27 and Ki-67 Proliferating Marker in Laryngeal Squamous Cell Carcinomas and in Laryngeal Papillomas.
    Anticancer Res. 2017;37:2407-2415.
    PubMed     Text format     Abstract available


    April 2017
  30. VEGH D, Banyai D, Hermann P, Nemeth Z, et al
    Type-2 Diabetes Mellitus and Oral Tumors in Hungary: A Long-term Comparative Epidemiological Study.
    Anticancer Res. 2017;37:1853-1857.
    PubMed     Text format     Abstract available


  31. DAVE E, Su W, Gupta V, Miles B, et al
    Human Papilloma Virus-positive Oropharyngeal Squamous Cell Carcinoma in the Elderly.
    Anticancer Res. 2017;37:1847-1851.
    PubMed     Text format     Abstract available


  32. JO S, Ha TK, Han SH, Kim ME, et al
    Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells via Mitochondria Dysfunction.
    Anticancer Res. 2017;37:1705-1710.
    PubMed     Text format     Abstract available


  33. P NS, Kang DY, Kim BJ, Joung YH, et al
    Methylsulfonylmethane Induces G1 Arrest and Mitochondrial Apoptosis in YD-38 Gingival Cancer Cells.
    Anticancer Res. 2017;37:1637-1646.
    PubMed     Text format     Abstract available


  34. SHIMIZU H, Shiozaki A, Fujiwara H, Konishi H, et al
    Short- and Long-term Progress of Recurrent Laryngeal Nerve Paralysis After Subtotal Esophagectomy.
    Anticancer Res. 2017;37:2019-2023.
    PubMed     Text format     Abstract available


  35. YUNOKI T, Tabuchi Y, Hayashi A
    Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
    Anticancer Res. 2017;37:1931-1934.
    PubMed     Text format     Abstract available


  36. FANG CY, Liew PL, Chen CL, Lin YH, et al
    High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1891-1899.
    PubMed     Text format     Abstract available


  37. FUJIMURA T, Takahashi K, Kambayashi Y, Furudate S, et al
    Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal Artery.
    Anticancer Res. 2017;37:1885-1889.
    PubMed     Text format     Abstract available


    March 2017
  38. WAKITA A, Motoyama S, Nanjo H, Sato Y, et al
    PD-L1 Expression Is a Prognostic Factor in Patients with Thoracic Esophageal Cancer Treated Without Adjuvant Chemotherapy.
    Anticancer Res. 2017;37:1433-1441.
    PubMed     Text format     Abstract available


  39. TORII C, Hida Y, Shindoh M, Akiyama K, et al
    Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1219-1225.
    PubMed     Text format     Abstract available


  40. NAKASHIMA S, Shiozaki A, Ichikawa D, Hikami S, et al
    Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1161-1167.
    PubMed     Text format     Abstract available


  41. TSENG HH, Tseng YK, You JJ, Kang BH, et al
    Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Anticancer Res. 2017;37:1059-1066.
    PubMed     Text format     Abstract available


  42. RUSSO M, Malandrino P, Moleti M, D'Angelo A, et al
    Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment.
    Anticancer Res. 2017;37:1515-1522.
    PubMed     Text format     Abstract available


  43. KOGASHIWA Y, Yasuda M, Sakurai H, Nakahira M, et al
    PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1417-1424.
    PubMed     Text format     Abstract available


  44. THEOCHARIS S, Kotta-Loizou I, Giaginis C, Alexandrou P, et al
    Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1313-1319.
    PubMed     Text format     Abstract available


  45. SAKAGAMI H, Masuda Y, Tomomura M, Yokose S, et al
    Quantitative Structure-Cytotoxicity Relationship of Chalcones.
    Anticancer Res. 2017;37:1091-1098.
    PubMed     Text format     Abstract available


  46. TAKEDA D, Hasegawa T, Ueha T, Iwata E, et al
    Induced Pluripotent-stem-cell Related Genes Contribute to De-differentiation in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1075-1082.
    PubMed     Text format     Abstract available


  47. HARA K, Miyazaki T, Yokobori T, Yoshida T, et al
    Significance and Function of MicroRNA-7 in Oesophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1043-1048.
    PubMed     Text format     Abstract available


  48. SAKAGAMI H, Okudaira N, Masuda Y, Amano O, et al
    Induction of Apoptosis in Human Oral Keratinocyte by Doxorubicin.
    Anticancer Res. 2017;37:1023-1029.
    PubMed     Text format     Abstract available


    February 2017
  49. SAKAGUCHI M, Maebayashi T, Aizawa T, Ishibashi N, et al
    Clinical Outcomes of Hypopharyngeal Cancer Receiving Definitive Radiotherapy with Concurrent Chemotherapy.
    Anticancer Res. 2017;37:941-947.
    PubMed     Text format     Abstract available


  50. SASAKI K, Uchikado Y, Okumura H, Omoto I, et al
    Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2017;37:859-864.
    PubMed     Text format     Abstract available


  51. GAMEZ ME, Agarwal M, Hu KS, Lukens JN, et al
    Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the "QUAD-SHOT Regimen".
    Anticancer Res. 2017;37:685-691.
    PubMed     Text format     Abstract available


  52. WICHMANN G, Cedra S, Schlegel D, Kolb M, et al
    Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo.
    Anticancer Res. 2017;37:521-527.
    PubMed     Text format     Abstract available


  53. VRANA D, Matzenauer M, Aujesky R, Vrba R, et al
    Potential Predictive Role of MicroRNAs in the Neoadjuvant Treatment of Esophageal Cancer.
    Anticancer Res. 2017;37:403-412.
    PubMed     Text format     Abstract available


  54. BOPPANA NB, Kraveka JM, Rahmaniyan M, Li LI, et al
    Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide.
    Anticancer Res. 2017;37:455-463.
    PubMed     Text format     Abstract available


  55. SIVARS L, Landin D, Grun N, Vlastos A, et al
    Validation of Human Papillomavirus as a Favourable Prognostic Marker and Analysis of CD8+ Tumour-infiltrating Lymphocytes and Other Biomarkers in Cancer of Unknown Primary in the Head and Neck Region.
    Anticancer Res. 2017;37:665-673.
    PubMed     Text format     Abstract available


  56. MEGWALU UC, Ma Y
    Racial Disparities in Oropharyngeal Cancer Stage at Diagnosis.
    Anticancer Res. 2017;37:835-839.
    PubMed     Text format     Abstract available


  57. HOCH S, Thelen K, Vorwerk H, Netzer C, et al
    Impact of Different Treatment Concepts on Regional Failure in Advanced Oropharyngeal Cancer.
    Anticancer Res. 2017;37:727-734.
    PubMed     Text format     Abstract available


    January 2017
  58. BAKST RL, Su W
    Identification and Management of Head and Neck Cancer Recurrences Detected on Adjuvant Radiation Oncology Simulation Scans.
    Anticancer Res. 2017;37:229-232.
    PubMed     Text format     Abstract available


  59. IMAI T, Oue N, Sentani K, Sakamoto N, et al
    KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells.
    Anticancer Res. 2017;37:47-55.
    PubMed     Text format     Abstract available


    December 2016
  60. LIU J, Motoyama S, Sato Y, Wakita A, et al
    Decreased Skeletal Muscle Mass After Neoadjuvant Therapy Correlates with Poor Prognosis in Patients with Esophageal Cancer.
    Anticancer Res. 2016;36:6677-6685.
    PubMed     Text format     Abstract available


  61. SHIRAI K, Saitoh JI, Musha A, Abe T, et al
    Clinical Outcomes of Definitive and Postoperative Radiotherapy for Stage I-IVB Hypopharyngeal Cancer.
    Anticancer Res. 2016;36:6571-6578.
    PubMed     Text format     Abstract available


  62. MIYAZAKI T, Sakai M, Sohda M, Tanaka N, et al
    Prognostic Significance of Inflammatory and Nutritional Parameters in Patients with Esophageal Cancer.
    Anticancer Res. 2016;36:6557-6562.
    PubMed     Text format     Abstract available


  63. SEIDL D, Schild SE, Wollenberg B, Hakim SG, et al
    Prognostic Factors in Patients Irradiated for Recurrent Head-and-Neck Cancer.
    Anticancer Res. 2016;36:6547-6550.
    PubMed     Text format     Abstract available


  64. OHASHI T, Komatsu S, Ichikawa D, Miyamae M, et al
    Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:6457-6466.
    PubMed     Text format     Abstract available


  65. MELLER S, VAN Ellen A, Gevensleben H, Bicker A, et al
    Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma Patients.
    Anticancer Res. 2016;36:6235-6241.
    PubMed     Text format     Abstract available


  66. DE FELICE F, Abate G, Galdieri A, Bulzonetti N, et al
    Impact of Induction Chemotherapy in Locally Advanced HPV-negative Oropharyngeal Cancer. A Propensity Score-matched analysis.
    Anticancer Res. 2016;36:6667-6672.
    PubMed     Text format     Abstract available


  67. GORPHE P, Matias M, Even C, Ferte C, et al
    Laryngo-esophageal Dysfunction-free Survival in a Preservation Protocol for T3 Laryngeal Squamous-cell Carcinoma.
    Anticancer Res. 2016;36:6625-6630.
    PubMed     Text format     Abstract available


  68. HAN MW, Lee JC, Park SY, Kim YM, et al
    Homotypic Interaction of Stabilin-2 Plays a Critical Role in Lymph Node Metastasis of Tongue Cancer.
    Anticancer Res. 2016;36:6611-6618.
    PubMed     Text format     Abstract available


  69. OBATA K, Shimo T, Okui T, Matsumoto K, et al
    Tachykinin Receptor 3 Distribution in Human Oral Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:6335-6341.
    PubMed     Text format     Abstract available


  70. LEE C, Siu A, Ramos DM
    Multicellular Spheroids as a Model for Hypoxia-induced EMT.
    Anticancer Res. 2016;36:6259-6263.
    PubMed     Text format     Abstract available


    November 2016
  71. VASSILIOU S, Nkenke E, Lefantzis N, Ioannidis A, et al
    Effect of Olmesartan on the Level of Oral Cancer Risk Factor PAI1.
    Anticancer Res. 2016;36:6093-6096.
    PubMed     Text format     Abstract available


  72. TAKANO K, Kakuki T, Obata K, Nomura K, et al
    The Behavior and Role of Lipolysis-stimulated Lipoprotein Receptor, a Component of Tricellular Tight Junctions, in Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2016;36:5895-5904.
    PubMed     Text format     Abstract available


  73. ASAKA S, Shimakawa T, Yamaguchi K, Murayama M, et al
    The Influence of Neoadjuvant Chemotherapy with Docetaxel, Nedaplatin and 5-Fluorouracil After Esophagectomy.
    Anticancer Res. 2016;36:6165-6171.
    PubMed     Text format     Abstract available


  74. KAMATA YU, Sumida T, Murase R, Nakano H, et al
    Blockade of Androgen-induced Malignant Phenotypes by Flutamide Administration in Human Salivary Duct Carcinoma Cells.
    Anticancer Res. 2016;36:6071-6075.
    PubMed     Text format     Abstract available


  75. SUZUKI R, Matsushima Y, Okudaira N, Sakagami H, et al
    Cytotoxic Components Against Human Oral Squamous Cell Carcinoma Isolated from Andrographis paniculata.
    Anticancer Res. 2016;36:5931-5935.
    PubMed     Text format     Abstract available


  76. HARADA K, Ferdous T, Ueyama Y
    Gimeracil Exerts Radiosensitizing Effects on Oral Squamous Cell Carcinoma Cells In Vitro and In Vivo.
    Anticancer Res. 2016;36:5923-5930.
    PubMed     Text format     Abstract available


    October 2016
  77. YAMAZAKI H, Demizu Y, Okimoto T, Ogita M, et al
    Comparison of Re-irradiation Outcomes for Charged Particle Radiotherapy and Robotic Stereotactic Radiotherapy Using CyberKnife for Recurrent Head and Neck Cancers: A Multi-institutional Matched-cohort Analysis.
    Anticancer Res. 2016;36:5507-5514.
    PubMed     Text format     Abstract available


  78. ATTRAMADAL CG, Kumar S, Gao J, Boysen ME, et al
    Low Mast Cell Density Predicts Poor Prognosis in Oral Squamous Cell Carcinoma and Reduces Survival in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:5499-5506.
    PubMed     Text format     Abstract available


  79. KUDOU M, Shiozaki A, Fujiwara H, Konishi H, et al
    Efficacy of PET-CT in the Diagnosis and Treatment of Recurrence After Esophageal Cancer Surgery.
    Anticancer Res. 2016;36:5473-5480.
    PubMed     Text format     Abstract available


  80. RADES D, Seidl D, Wollenberg B, Schild SE, et al
    Radiochemotherapy with Paclitaxel for Recurrent Previously Irradiated Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:5463-5468.
    PubMed     Text format     Abstract available


  81. KITAGAWA H, Namikawa T, Munekage M, Fujisawa K, et al
    Analysis of Factors Associated with Weight Loss After Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2016;36:5409-5412.
    PubMed     Text format     Abstract available


  82. MORIKAWA T, Koto M, Hasegawa A, Takagi R, et al
    Radiation-induced Parotid Gland Atrophy in Patients with Head and Neck Cancer After Carbon-ion Radiotherapy.
    Anticancer Res. 2016;36:5403-5407.
    PubMed     Text format     Abstract available


  83. LEE M, Ryu CH, Chang HW, Kim GC, et al
    Radiotherapy-associated Furin Expression and Tumor Invasiveness in Recurrent Laryngeal Cancer.
    Anticancer Res. 2016;36:5117-5125.
    PubMed     Text format     Abstract available


  84. DAMASKOS C, Valsami S, Spartalis E, Antoniou EA, et al
    Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?
    Anticancer Res. 2016;36:5019-5024.
    PubMed     Text format     Abstract available


  85. MEGWALU UC
    Exploring the Use of Oropharyngeal Cancer Histology to Account for HPV Status in Population-based Studies.
    Anticancer Res. 2016;36:5515-5518.
    PubMed     Text format     Abstract available


  86. KNIEF J, Reddemann K, Petrova E, Herhahn T, et al
    High Density of Tumor-infiltrating B-Lymphocytes and Plasma Cells Signifies Prolonged Overall Survival in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2016;36:5339-5345.
    PubMed     Text format     Abstract available


    September 2016
  87. KIKUCHI M, Nakajima M, Muroi H, Takahashi M, et al
    Significance of Expression of Complement C4d in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:4553-7.
    PubMed     Text format     Abstract available


  88. MATSUMURA Y, Hiraoka K, Ishikawa K, Shoji Y, et al
    CD40 Expression in Human Esophageal Squamous Cell Carcinoma Is Associated with Tumor Progression and Lymph Node Metastasis.
    Anticancer Res. 2016;36:4467-75.
    PubMed     Text format     Abstract available


    August 2016
  89. GROSS M, Meirovich A, Rachmut J, Kalichman I, et al
    The Diagnostic and Prognostic Value of sIL-2R as an Immune Biomarker in Head and Neck Cancers.
    Anticancer Res. 2016;36:4347-52.
    PubMed     Text format     Abstract available


  90. DE FELICE F, Musio D, Bulzonetti N, Maghella F, et al
    Target Volume Delineation Based on Diffusion-weighted magnetic Resonance Imaging for Locally Advanced Head and Neck Cancer.
    Anticancer Res. 2016;36:4181-5.
    PubMed     Text format     Abstract available


  91. THEODORAKI MN, Lorenz KJ, Schneider J, Thierauf JC, et al
    Influence of Photodynamic Therapy on the Expression of Cancer/Testis Antigens in Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:3973-82.
    PubMed     Text format     Abstract available


  92. SAYAN M, Vempati P, Miles B, Teng M, et al
    Adjuvant Therapy for Salivary Gland Carcinomas.
    Anticancer Res. 2016;36:4165-70.
    PubMed     Text format     Abstract available


  93. ISRAEL Y, Rachmiel A, Ziv G, Nagler R, et al
    Benign and Malignant Salivary Gland Tumors - Clinical and Demographic Characteristics.
    Anticancer Res. 2016;36:4151-4.
    PubMed     Text format     Abstract available


  94. SUMIDA T, Kobayashi Y, Ishikawa A, Shinohara K, et al
    Bite Force and Masticatory Performance Using Implant-supported Overdentures After Treatment of Mandibular Cancer.
    Anticancer Res. 2016;36:4077-80.
    PubMed     Text format     Abstract available


  95. KITAGAWA H, Yatabe T, Namikawa T, Munekage M, et al
    Postoperative Closed-loop Glycemic Control Using an Artificial Pancreas in Patients After Esophagectomy.
    Anticancer Res. 2016;36:4063-7.
    PubMed     Text format     Abstract available


  96. MORITA M, Saeki H, Nakaji YU, Zaitsu Y, et al
    Conversion to Neuroendocrine Carcinoma from Squamous Cell Carcinoma of the Esophagus After Definitive Chemoradiotherapy.
    Anticancer Res. 2016;36:4045-9.
    PubMed     Text format     Abstract available


  97. MAYS AC, Feng X, Browne JD, Sullivan CA, et al
    Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma.
    Anticancer Res. 2016;36:4013-8.
    PubMed     Text format     Abstract available


  98. ZATONSKI T, Ciesielska U, Nowinska K, Ratajczak-Wielgomas K, et al
    Expression of Cell Cycle-Related Proteins p16, p27, p53 and Ki-67 in HPV-positive and -negative Samples of Papillomas of the Upper Respiratory Tract.
    Anticancer Res. 2016;36:3917-24.
    PubMed     Text format     Abstract available


  99. SUMIDA T, Kamata YU, Kobayashi Y, Ishikawa A, et al
    ID1 Controls Aggressiveness of Salivary Gland Cancer Cells via Crosstalk of IGF and AKT Pathways.
    Anticancer Res. 2016;36:3865-70.
    PubMed     Text format     Abstract available


  100. LEE C, Ramos DM
    Regulation of Multicellular Spheroids by MAPK and FYN Kinase.
    Anticancer Res. 2016;36:3833-8.
    PubMed     Text format     Abstract available


  101. KARAGIANNIS AK, Girio-Fragkoulakis C, Nakouti T
    Procalcitonin: A New Biomarker for Medullary Thyroid Cancer? A Systematic Review.
    Anticancer Res. 2016;36:3803-10.
    PubMed     Text format     Abstract available



  102. Salivary Gland Neoplasms.
    Anticancer Res. 2016;36:4372.
    PubMed     Text format    


    July 2016
  103. TSAI CW, Chang WS, Gong CL, Shih LC, et al
    Contribution of Matrix Metallopeptidase-1 Genotypes, Smoking, Alcohol Drinking and Areca Chewing to Nasopharyngeal Carcinoma Susceptibility.
    Anticancer Res. 2016;36:3335-3340.
    PubMed     Text format     Abstract available


  104. JOHNSON SD, Levingston C, Young MR
    Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells.
    Anticancer Res. 2016;36:3261-70.
    PubMed     Text format     Abstract available


  105. FRANZESE C, Fogliata A, Franceschini D, Clerici E, et al
    Treatment: Outcome and Toxicity of Volumetric Modulated Arc Therapy in Oropharyngeal Carcinoma.
    Anticancer Res. 2016;36:3451-7.
    PubMed     Text format     Abstract available


    June 2016

  106. Targeting Oral Cancer.
    Anticancer Res. 2016;36:3224.
    PubMed     Text format    


  107. KOBAYASHI Y, Sumida T, Ishikawa A, Mori Y, et al
    The Contribution of Dental Implants to Functional Artificial Restoration After Treatment of Oral Cancer.
    Anticancer Res. 2016;36:3053-6.
    PubMed     Text format     Abstract available


  108. AMPIL F, Caldito G, Vora M, Richards T, et al
    Ten-year Survivors After Contemporary Management of Advanced 'Horseshoe' Anterior Commissure Laryngeal Cancer.
    Anticancer Res. 2016;36:3049-52.
    PubMed     Text format     Abstract available


  109. RADES D, Janssen S, Bajrovic A, Strojan P, et al
    A Total Radiation Dose of 70 Gy Is Required After Macroscopically Incomplete Resection of Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:2989-92.
    PubMed     Text format     Abstract available


  110. MEGWALU UC, Panossian H
    Survival Outcomes in Early Stage Laryngeal Cancer.
    Anticancer Res. 2016;36:2903-7.
    PubMed     Text format     Abstract available


  111. BOYSEN ME, Zatterstrom UK, Evensen JF
    Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases.
    Anticancer Res. 2016;36:2849-54.
    PubMed     Text format     Abstract available


  112. WIEST I, Alexiou C, Friese K, Betz P, et al
    Expression of the Tumor-associated Mucin 1 Epitope Analyzed with the Humanized PankoMab-GEX Antibody in Malignant and Normal Tissues of the Head and Neck.
    Anticancer Res. 2016;36:3179-84.
    PubMed     Text format     Abstract available


  113. FRIEDRICH RE, Wunder T, Schumacher U, Bartel-Friedrich S, et al
    Expression of DOG1 (Using SP31) in Poorly Differentiated Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:3117-22.
    PubMed     Text format     Abstract available


  114. GORKA E, Fabo D, Gezsi A, Czirbesz K, et al
    Distance from Primary Tumor Is the Strongest Predictor for Early Onset of Brain Metastases in Melanoma.
    Anticancer Res. 2016;36:3065-9.
    PubMed     Text format     Abstract available


  115. MEGWALU UC, Green RW
    Total Thyroidectomy Versus Lobectomy for the Treatment of Follicular Thyroid Microcarcinoma.
    Anticancer Res. 2016;36:2899-902.
    PubMed     Text format     Abstract available


  116. KRAMER B, Hock C, Birk R, Sauter A, et al
    Targeted Therapies in HPV-positive and -negative HNSCC - Alteration of EGFR and VEGFR-2 Expression In Vitro.
    Anticancer Res. 2016;36:2799-807.
    PubMed     Text format     Abstract available


  117. SUMIDA T, Ishikawa A, Kamata YU, Nakano H, et al
    Estrogen Enhances Malignant Phenotypes in Human Salivary Adenoid Cystic Carcinoma Cells.
    Anticancer Res. 2016;36:2793-8.
    PubMed     Text format     Abstract available


  118. MASUI M, Okui T, Shimo T, Takabatake K, et al
    Novel Midkine Inhibitor iMDK Inhibits Tumor Growth and Angiogenesis in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:2775-81.
    PubMed     Text format     Abstract available


    May 2016
  119. SEIDL D, Janssen S, Strojan P, Bajrovic A, et al
    Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer.
    Anticancer Res. 2016;36:2523-6.
    PubMed     Text format     Abstract available


  120. SEIDL D, Janssen S, Strojan P, Hakim SG, et al
    Importance of Chemotherapy and Radiation Dose After Microscopically Incomplete Resection of Stage III/IV Head and Neck Cancer.
    Anticancer Res. 2016;36:2487-91.
    PubMed     Text format     Abstract available


  121. HSU CM, Lin PM, Lin HC, Lai CC, et al
    Altered Expression of Imprinted Genes in Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2016;36:2251-8.
    PubMed     Text format     Abstract available


  122. TONISSI F, Lattanzio L, Astesana V, Cavicchioli F, et al
    Reoxygenation Reverses Hypoxia-related Radioresistance in Head and Neck Cancer Cell Lines.
    Anticancer Res. 2016;36:2211-5.
    PubMed     Text format     Abstract available


  123. SHIBATA A, Ibaragi S, Mandai H, Tsumura T, et al
    Synthetic Terrein Inhibits Progression of Head and Neck Cancer by Suppressing Angiogenin Production.
    Anticancer Res. 2016;36:2161-8.
    PubMed     Text format     Abstract available


  124. RANTANEN T, Oksala N, Sand J
    Adenocarcinoma of the Oesophagus and Oesophagogastric Junction: Analysis of Incidence and Risk Factors.
    Anticancer Res. 2016;36:2323-9.
    PubMed     Text format     Abstract available


  125. HAKELIUS M, Reyhani V, Rubin K, Gerdin B, et al
    Normal Oral Keratinocytes and Head and Neck Squamous Carcinoma Cells Induce an Innate Response of Fibroblasts.
    Anticancer Res. 2016;36:2131-7.
    PubMed     Text format     Abstract available


    April 2016
  126. MATSUMOTO A, Nishikawa K, Yuda M, Tanaka Y, et al
    Early Response of Esophageal Cancer to Neoadjuvant Chemotherapy with Docetaxel-Cisplatin-5-Fluorouracil Represents Sensitivity: A Phase II Study.
    Anticancer Res. 2016;36:1937-42.
    PubMed     Text format     Abstract available


  127. KANEKIYO S, Takeda S, Nakajima M, Nishiyama M, et al
    Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer.
    Anticancer Res. 2016;36:1923-7.
    PubMed     Text format     Abstract available


  128. DANG RP, LE VH, Miles BA, Teng MS, et al
    Clinical Outcomes in Patients with Recurrent or Metastatic Human Papilloma Virus-positive Head and Neck Cancer.
    Anticancer Res. 2016;36:1703-9.
    PubMed     Text format     Abstract available


  129. MOLES MA, Montoya JA, Salvago MD, Avila IR, et al
    Implications of Differential Expression of beta-Catenin in Oral Carcinoma.
    Anticancer Res. 2016;36:1599-604.
    PubMed     Text format     Abstract available


  130. RADES D, Janssen S, Kasmann L, Bolm L, et al
    Outcomes After Irradiation of Epidural Spinal Cord Compression Due to Metastatic Thyroid Cancer.
    Anticancer Res. 2016;36:2035-9.
    PubMed     Text format     Abstract available


    March 2016
  131. IWASAKI K, Osaka Y, Tachibana S, Suda T, et al
    Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local or Metastatic Esophageal Cancer.
    Anticancer Res. 2016;36:987-94.
    PubMed     Text format     Abstract available


  132. HOCH S, Bohne F, Franke N, Wilhelm T, et al
    Extent of Salvage Neck Dissection in Advanced Oro- and Hypopharyngeal Cancer.
    Anticancer Res. 2016;36:981-6.
    PubMed     Text format     Abstract available


  133. BLEDSOE TJ, Noble AR, Reddy CA, Burkey BB, et al
    Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or Infirm.
    Anticancer Res. 2016;36:933-9.
    PubMed     Text format     Abstract available


    February 2016
  134. LONDERO SC, Jespersen ML, Krogdahl A, Bastholt L, et al
    Gene-expression Classifier in Papillary Thyroid Carcinoma: Validation and Application of a Classifier for Prognostication.
    Anticancer Res. 2016;36:749-56.
    PubMed     Text format     Abstract available


  135. LU YC, Lin ML, Su HL, Chen SS, et al
    ER-Dependent Ca++-mediated Cytosolic ROS as an Effector for Induction of Mitochondrial Apoptotic and ATM-JNK Signal Pathways in Gallic Acid-treated Human Oral Cancer Cells.
    Anticancer Res. 2016;36:697-705.
    PubMed     Text format     Abstract available


  136. TURUNEN A, Hukkanen V, Kulmala J, Syrjanen S, et al
    HSV-1 Infection Modulates the Radioresponse of a HPV16-positive Head and Neck Cancer Cell Line.
    Anticancer Res. 2016;36:565-74.
    PubMed     Text format     Abstract available


  137. SIVARS L, Tani E, Nasman A, Ramqvist T, et al
    Human Papillomavirus as a Diagnostic and Prognostic Tool in Cancer of Unknown Primary in the Head and Neck Region.
    Anticancer Res. 2016;36:487-93.
    PubMed     Text format     Abstract available


  138. OJIMA T, Nakamori M, Nakamura M, Katsuda M, et al
    Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus.
    Anticancer Res. 2016;36:829-34.
    PubMed     Text format     Abstract available


  139. NOBLE AR, Greskovich JF, Han J, Reddy CA, et al
    Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
    Anticancer Res. 2016;36:785-92.
    PubMed     Text format     Abstract available


  140. WINTHER M, Alsner J, Sorensen BS, Wittrup CF, et al
    Hypoxia-regulated MicroRNAs in Gastroesophageal Cancer.
    Anticancer Res. 2016;36:721-30.
    PubMed     Text format     Abstract available


    January 2016

  141. Esophageal Cancer. Prevention, Diagnosis and Therapy.
    Anticancer Res. 2016;36:481.
    PubMed     Text format    


  142. TANI Y, Nakajima M, Kikuchi M, Ihara K, et al
    18F-Fluorodeoxyglucose Positron Emission Tomography for Evaluating the Response to Neoadjuvant Chemotherapy in Advanced Esophageal Cancer.
    Anticancer Res. 2016;36:367-73.
    PubMed     Text format     Abstract available


  143. JI Y, Li X, Li Y, Zhong Y, et al
    Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:343-9.
    PubMed     Text format     Abstract available


  144. MEHTA V, Shi Z, Mills GM, Nathan CA, et al
    Effect of Payer Status on Relative Survival of Patients with Laryngeal Cancer.
    Anticancer Res. 2016;36:327-33.
    PubMed     Text format     Abstract available


  145. ALHAZZAZI TY, Kamarajan P, Xu Y, Ai T, et al
    A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells.
    Anticancer Res. 2016;36:49-60.
    PubMed     Text format     Abstract available


  146. KANTHAMNENI N, Yung B, Lee RJ
    Effect of Eudragit on In Vitro Transfection Efficiency of PEI-DNA Complexes.
    Anticancer Res. 2016;36:81-5.
    PubMed     Text format     Abstract available


  147. ADAMS S, Lin J, Brown D, Shriver CD, et al
    Ultraviolet Radiation Exposure and the Incidence of Oral, Pharyngeal and Cervical Cancer and Melanoma: An Analysis of the SEER Data.
    Anticancer Res. 2016;36:233-7.
    PubMed     Text format     Abstract available


    December 2015
  148. KOMATSU M, Arai Y, Yabuki K, Sano D, et al
    Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma.
    Anticancer Res. 2015;35:6861-7.
    PubMed     Text format     Abstract available


  149. SONG JH, Jeong BK, Choi HS, Jeong H, et al
    Comparison of Failure Patterns Between Conventional and Intensity-modulated Radiotherapy for Stage III and IV Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2015;35:6833-40.
    PubMed     Text format     Abstract available


  150. KIM SH, Kang JG, Kim CS, Ihm SH, et al
    Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells.
    Anticancer Res. 2015;35:6529-37.
    PubMed     Text format     Abstract available


  151. OKUMURA H, Uchikado Y, Omoto I, Motomura M, et al
    Ferredoxin Reductase Is Useful for Predicting the Effect of Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2015;35:6471-4.
    PubMed     Text format     Abstract available


  152. PAPADAKIS G, Kalaitzidou S, Triantafillou E, Drosou A, et al
    Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
    Anticancer Res. 2015;35:6933-40.
    PubMed     Text format     Abstract available


    November 2015
  153. DOLL C, Arsenic R, Lage H, Johrens K, et al
    Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade.
    Anticancer Res. 2015;35:5867-72.
    PubMed     Text format     Abstract available


  154. GALLO K, Brickman A, Warren WH, Gattuso P, et al
    Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma.
    Anticancer Res. 2015;35:6325-7.
    PubMed     Text format     Abstract available


  155. KITAGAWA H, Namikawa T, Munekage M, Akimori T, et al
    Visualization of the Stomach's Arterial Networks During Esophageal Surgery Using the HyperEye Medical System.
    Anticancer Res. 2015;35:6201-5.
    PubMed     Text format     Abstract available


  156. KLAIRMONT M, Kopkash K, Favuzza J, Hill M, et al
    Four Synchronous Primary Malignancies of the Breast, Lung, Colon and Esophagus.
    Anticancer Res. 2015;35:6159-62.
    PubMed     Text format     Abstract available


  157. ATTRAMADAL CG, Kumar S, Boysen ME, Dhakal HP, et al
    Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
    Anticancer Res. 2015;35:6111-20.
    PubMed     Text format     Abstract available


    October 2015
  158. MANYAM BV, Nwizu TI, Rahe ML, Harr BA, et al
    Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report.
    Anticancer Res. 2015;35:5511-4.
    PubMed     Text format     Abstract available


  159. SUROV A, Gottschling S, Wienke A, Meyer HJ, et al
    Primary Thyroid Sarcoma: A Systematic Review.
    Anticancer Res. 2015;35:5185-91.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: